Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
12%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IBRN
53
HOLDINGS
32%
ALSO IN SBIO
SBIO
94
HOLDINGS
14%
ALSO IN IBRN
SECTOR DRIFT (IBRN minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBRN |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
ALKERMES PLC | 3.4% | 2.7% | 2.7% | |
ACADIA PHARMACEUTICALS INC | 4.6% | 2.6% | 2.6% | |
PTC THERAPEUTICS INC | 3.6% | 2.2% | 2.2% | |
DENALI THERAPEUTICS INC. | 3.9% | 1.3% | 1.3% | |
EDGEWISE THERAPEUTICS, INC. | 2.2% | 0.8% | 0.8% |
IBRN Overweight Relative to SBIO
SUPERNUS PHARMACEUTICALS INC | 5.0% | |
ARGENX SE ADR | 4.6% | |
SK BIOPHARMACEUTICALS CO., LTD. | 4.4% | |
NEUROCRINE BIOSCIENCES INC | 4.1% | |
BIOGEN IDEC INC | 4.0% | |
SCHOLAR ROCK HOLDING CORP. | 3.8% | |
CATALYST PHARMACEUTICAL PART | 3.1% | |
DENALI THERAPEUTICS INC. | 2.6% | |
SANBIO CO., LTD. | 2.3% | |
DYNE THERAPEUTICS INC | 2.2% |
IBRN Underweight Relative to SBIO
RHYTHM PHARMACEUTICALS, INC. | -3.6% | |
AVIDITY BIOSCIENCES INC | -3.5% | |
AXSOME THERAPEUTICS, INC. | -3.2% | |
NUVALENT, INC. CLASS A | -3.1% | |
MERUS N.V. | -3.0% | |
VIKING THERAPEUTICS, INC. | -2.6% | |
CYTOKINETICS INC | -2.5% | |
AKERO THERAPEUTICS, INC. | -2.5% | |
KRYSTAL BIOTECH, INC. | -2.5% | |
ZAI LAB LTD. UNSPONSORED ADR | -2.4% |